Erratum to: Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination

Published September 13, 2022
Read in PDF Format

Authors

Owen Jensen^1,2, Shubhanshi Trivedi¹, Jackson G. Cacioppo³, Kelin Li³, Jeffrey Aubé³, J. Scott Hale², Edward T. Ryan^4,5,6, Daniel T. Leung^{1, 2*}

Affiliated Institutions

¹ Division of Infectious Diseases, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah
² Division of Microbiology & Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah
³Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
⁴ Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts
⁵ Department of Medicine, Harvard Medical School, Boston, Massachusetts
⁶ Department of Immunology and Infectious diseases, Harvard School of Public Health, Boston, Massachusetts

Corresponding Author

Daniel T. Leung
E-mail: daniel.leung@utah.edu

Suggested Citation

Jensen O, Trivedi S, Cacioppo JG, Li K, Aubé J, Hale JS, Ryan ET, Leung DT. Use of a MAIT Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination. Pathogens and Immunity. 2022;7(1):145-146. doi: 10.20411/pai.v7i1.541.

DOI

10.20411/pai.v7i1.541

Erratum to: Use of a MAIT Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination

doi: 10.20411/pai.v7i1.525

Reason: The authors sincerely regret the inadvertent omission of Jackson G. Cacioppo as coauthor of this work. He has no additional conflicts of interest.

Corrected version: Owen Jensen^1,2, Shubhanshi Trivedi¹, Jackson G. Cacioppo³, Kelin Li³, Jeffrey Aubé³, J. Scott Hale², Edward T. Ryan^4,5,6, Daniel T. Leung^{1, 2*}

Footnotes

Submitted September 8, 2022 | Accepted September 8, 2022 | Published September 13, 2022